Future studies should explore additional biomarkers, such as chromogranin A (CgA) and cytokines like IL-6, to further unravel the immune-inflammatory pathways involved in ADHD, enhancing diagnostic accuracy and therapeutic monitoring [81,94]. Here, IL6 is linked to attention deficit-hyperactivity disorder.